Treatment and Prevention of AFib

Translate to Spanish or other 102 languages!

Although no one can guarantee that a stroke or a clot is preventable, there are ways to reduce risks. Image for illustration purposes
Although no one can guarantee that a stroke or a clot is preventable, there are ways to reduce risks. Image for illustration purposes
- Advertisement -

American Heart Association

Know your treatment goals

The treatment goals of atrial fibrillation, also called AF or AFib, start with a proper diagnosis through an in-depth examination from a doctor. The exam usually includes questions about your history and an electrocardiogram. Some patients may need a thorough electrophysiology study. Read about AFib treatment options.

- Advertisement -

Prevention and risk reduction

Although no one can guarantee that a stroke or a clot is preventable, there are ways to reduce risks.

After being diagnosed with AFib, the ideal goals may include:

  • Restoring the heart to a normal rhythm (called rhythm control)
  • Reducing an overly high heart rate (called rate control)
  • Preventing blood clots
  • Managing risk factors for stroke
  • Preventing additional heart rhythm problems
  • Preventing heart failure

Your doctor may recommend adopting lifestyle changes, including those listed below:

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Sun Allergy Is Real: Signs, Causes, and How to Protect Your Skin

Is it possible to have a sun allergy? It may feel that way on a hot day, but for some people, that’s actually the case.

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -